maxiseptic (1 mg + 20 mg)/ml aerozol na skórę, roztwór
bausch health ireland ltd. - octenidini dihydrochloridum + phenoxyethanol - aerozol na skórę, roztwór - (1 mg + 20 mg)/ml
dexak 25 mg roztwór doustny w saszetce
berlin-chemie ag - dexketoprofenum - roztwór doustny w saszetce - 25 mg
protecta vr model d364vrm - defibrillator, implantable, automatic
mhyosphere pcv id
laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - wieprzowy - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.
micafungin zentiva 50 mg proszek do sporządzania koncentratu roztworu do infuzji
zentiva, k.s. - micafunginum - proszek do sporządzania koncentratu roztworu do infuzji - 50 mg
micafungin zentiva 100 mg proszek do sporządzania koncentratu roztworu do infuzji
zentiva, k.s. - micafunginum - proszek do sporządzania koncentratu roztworu do infuzji - 100 mg
akvir o smaku malinowym 250 mg/5 ml syrop
zakłady farmaceutyczne polpharma s.a. - inosinum pranobexum - syrop - 250 mg/5 ml
akvir forte o smaku malinowym 500 mg/5 ml syrop
zakłady farmaceutyczne polpharma s.a. - inosinum pranobexum - syrop - 500 mg/5 ml
akvir o smaku truskawkowym 250 mg/5 ml syrop
zakłady farmaceutyczne polpharma s.a. - inosinum pranobexum - syrop - 250 mg/5 ml
akvir forte o smaku truskawkowym 500 mg/5 ml syrop
zakłady farmaceutyczne polpharma s.a. - inosinum pranobexum - syrop - 500 mg/5 ml